Article

Genetic risk for Alzheimer’s disease, and differential trajectories in circulating blood biomarkers in UK Biobank (n=17,817)

2025-08-13

Abstract excerpt

<title>Abstract</title> Understanding pathways from genetic variation to cognitive impairment is critical for dementia prevention, risk stratification and the development of treatments. While genetic risk factors for dementia are known to associate with cross-sectional differences in biomarkers (e.g. lipids) in healthy people, potential influence over longitudinal trajectories is not understood.We leveraged ge...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 172d1b87-4560-5d8d-84c3-d1231760ee45
DOI: 10.21203/rs.3.rs-6802545/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Genetic risk for Alzheimer’s disease, and differential trajectories in circulating blood biomarkers in UK Biobank (n=17,817)DOI 10.21203/rs.3.rs-6802545/v1Read

Alzheimer’s disease susceptibility gene apolipoprotein e (APOE) and blood biomarkers in UK Biobank (N=395,769)Semantic proximity Read

Heterogeneous effects of genetic risk for Alzheimer's disease on the phenome.Semantic proximity Read

Alzheimer's Disease Susceptibility Gene Apolipoprotein E (APOE) and Blood Biomarkers in UK Biobank (N = 395,769).Semantic proximity Read

The causes and consequences of Alzheimer’s disease: phenome-wide evidence from Mendelian randomizationSemantic proximity Read

Genetic versus Modifiable Risk: Predicting Dementia, Cognition, and Brain Structure in the UK BiobankSemantic proximity Read

Effects of genetic liability to Alzheimer’s disease on circulating metabolites across the life courseSemantic proximity Read

Plasma proteomics of APOE genotype: age-specific analyses in UK population-based cohortsSemantic proximity Read

Interrogating the complex relationship between Alzheimer’s disease and blood pressure: two instrumental variable approaches to focus on pre-clinical stages of Alzheimer’s disease in UK BiobankSemantic proximity Read

A non- APOE Polygenic score for Alzheimer’s disease and APOE-ε4 have independent associations with dementia in the Health and Retirement StudySemantic proximity Read

Novel Plasma Proteins Associated With Alzheimer’s Disease Risk in APOE ε4 Carriers and Non-carriersSemantic proximity Read

Genetic Associations Between Modifiable Risk Factors and Alzheimer DiseaseSemantic proximity Read

Apolipoprotein E in Alzheimer's disease trajectories and the next-generation clinical care pathway.Semantic proximity Read